Vaxcyte, Inc. (PCVX)
45.84
+0.52
(+1.15%)
USD |
NASDAQ |
Jan 09, 14:41
Vaxcyte EPS Diluted (Quarterly): -1.563 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Novavax, Inc. | -1.246 |
| Thermo Fisher Scientific, Inc. | 4.275 |
| Moderna, Inc. | -0.5128 |
| Eli Lilly & Co. | 6.211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -212.83M |
| Total Expenses (Quarterly) | 212.83M |
| Enterprise Value | 4.306B |
| Earnings Yield | -10.74% |
| Normalized Earnings Yield | -10.74 |